Hogg D - Search Results

1

Concurrent acute lymphoblastic leukemia and juvenile pilocytic astrocytoma in a pediatric patient.

Kim AL, Fernandez CV, Greer WL, Hogg D, Lassam NJ, Resch L. Kim AL, et al. Among authors: hogg d. J Pediatr Hematol Oncol. 2000 Sep-Oct;22(5):451-3. doi: 10.1097/00043426-200009000-00013. J Pediatr Hematol Oncol. 2000. PMID: 11037859

2

CDKN2A mutations in multiple primary melanomas.

Monzon J, Liu L, Brill H, Goldstein AM, Tucker MA, From L, McLaughlin J, Hogg D, Lassam NJ. Monzon J, et al. Among authors: hogg d. N Engl J Med. 1998 Mar 26;338(13):879-87. doi: 10.1056/NEJM199803263381305. N Engl J Med. 1998. PMID: 9516223 Free article.

3

Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.

Lal G, Liu L, Hogg D, Lassam NJ, Redston MS, Gallinger S. Lal G, et al. Among authors: hogg d. Genes Chromosomes Cancer. 2000 Apr;27(4):358-61. Genes Chromosomes Cancer. 2000. PMID: 10719365

4

Genetic Testing in Familial Melanoma : Epidemiologic/Genetic Assessment of Risks and Role of CDKN2A Analysis.

Hogg D, Liu L, Lassam N. Hogg D, et al. Methods Mol Med. 2001;61:109-22. doi: 10.1385/1-59259-145-0:109. Methods Mol Med. 2001. PMID: 22323255

5

Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma.

Liu L, Lassam NJ, Slingerland JM, Bailey D, Cole D, Jenkins R, Hogg D. Liu L, et al. Among authors: hogg d. Oncogene. 1995 Jul 20;11(2):405-12. Oncogene. 1995. PMID: 7624155

6

Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF.

Liu L, Goldstein AM, Tucker MA, Brill H, Gruis NA, Hogg D, Lassam NJ. Liu L, et al. Among authors: hogg d. Genes Chromosomes Cancer. 1997 May;19(1):52-4. Genes Chromosomes Cancer. 1997. PMID: 9135995

7

Absence of the L37P polymorphism in exon 1 of the CDKN2A gene.

Fung JJ, Liu L, Gao L, Monzon J, Lassam NJ, Hogg D. Fung JJ, et al. Among authors: hogg d. Mol Cell Probes. 1997 Jun;11(3):231-2. doi: 10.1006/mcpr.1997.0098. Mol Cell Probes. 1997. PMID: 9232623 No abstract available.

8

Role of the cyclin-dependent kinase inhibitor CDKN2A in familial melanoma.

Hogg D, Brill H, Liu L, Monzon J, Summers A, From L, Lassam NJ. Hogg D, et al. J Cutan Med Surg. 1998 Jan;2(3):172-9. doi: 10.1177/120347549800200312. J Cutan Med Surg. 1998. PMID: 9479083 Review.

9

CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein.

Sun S, Pollock PM, Liu L, Karimi S, Jothy S, Milner BJ, Renwick A, Lassam NJ, Hayward NK, Hogg D, Narod SA, Foulkes WD. Sun S, et al. Among authors: hogg d. Int J Cancer. 1997 Nov 14;73(4):531-6. doi: 10.1002/(sici)1097-0215(19971114)73:4<531::aid-ijc13>3.0.co;2-c. Int J Cancer. 1997. PMID: 9389568

10

Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.

Gao L, Liu L, van Meyel D, Cairncross G, Forsyth P, Kimmel D, Jenkins RB, Lassam NJ, Hogg D. Gao L, et al. Among authors: hogg d. Clin Cancer Res. 1997 Jun;3(6):977-81. Clin Cancer Res. 1997. PMID: 9815774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters